Phase 1 AML, Adult Recurrent Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
BSB-1001 in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant for AML, ALL or MDS
MDSAML, Adult RecurrentALL, Recurrent, Adult
BlueSphere Bio, Inc38 enrolled6 locationsNCT06704152
Recruiting
Phase 1
A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)
MDSAML, Adult Recurrent
PureTech90 enrolled9 locationsNCT05829226
Recruiting
Phase 1Phase 2
Sequential CAR-T Cells Targeting CD33/CD123 in Patients With Acute Myelocytic Leukemia AML
Acute Myeloid LeukemiaAMLAML, Adult+1 more
Essen Biotech85 enrolled1 locationNCT06420063
Recruiting
Phase 1
A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients
AML, Adult RecurrentNHL, Adult
Shengke Pharmaceuticals (Jiangsu) Limited, China60 enrolled2 locationsNCT05758610